File Download
  Links for fulltext
     (May Require Subscription)
Supplementary

Article: Elemental arsenic entered the cerebrospinal fluid during oral arsenic trioxide treatment of meningeal relapse of acute promyelocytic leukemia

TitleElemental arsenic entered the cerebrospinal fluid during oral arsenic trioxide treatment of meningeal relapse of acute promyelocytic leukemia
Authors
Issue Date2006
PublisherAmerican Society of Hematology. The Journal's web site is located at http://bloodjournal.hematologylibrary.org/
Citation
Blood, 2006, v. 107 n. 7, p. 3012-3013 How to Cite?
Persistent Identifierhttp://hdl.handle.net/10722/162958
ISSN
2023 Impact Factor: 21.0
2023 SCImago Journal Rankings: 5.272
ISI Accession Number ID
References

 

DC FieldValueLanguage
dc.contributor.authorAu, WYen_US
dc.contributor.authorTam, Sen_US
dc.contributor.authorFong, BMen_US
dc.contributor.authorKwong, YLen_US
dc.date.accessioned2012-09-05T05:25:54Z-
dc.date.available2012-09-05T05:25:54Z-
dc.date.issued2006en_US
dc.identifier.citationBlood, 2006, v. 107 n. 7, p. 3012-3013en_US
dc.identifier.issn0006-4971en_US
dc.identifier.urihttp://hdl.handle.net/10722/162958-
dc.languageengen_US
dc.publisherAmerican Society of Hematology. The Journal's web site is located at http://bloodjournal.hematologylibrary.org/en_US
dc.relation.ispartofBlooden_US
dc.subject.meshAdministration, Oralen_US
dc.subject.meshAntineoplastic Agents - Therapeutic Useen_US
dc.subject.meshArsenic - Blood - Cerebrospinal Fluiden_US
dc.subject.meshArsenicals - Administration & Dosage - Pharmacokinetics - Therapeutic Useen_US
dc.subject.meshHumansen_US
dc.subject.meshLeukemia, Promyelocytic, Acute - Blood - Cerebrospinal Fluid - Drug Therapyen_US
dc.subject.meshMaleen_US
dc.subject.meshMeningeal Neoplasms - Blood - Cerebrospinal Fluid - Drug Therapy - Secondaryen_US
dc.subject.meshMiddle Ageden_US
dc.subject.meshOxides - Administration & Dosage - Pharmacokinetics - Therapeutic Useen_US
dc.subject.meshRecurrenceen_US
dc.titleElemental arsenic entered the cerebrospinal fluid during oral arsenic trioxide treatment of meningeal relapse of acute promyelocytic leukemiaen_US
dc.typeArticleen_US
dc.identifier.emailKwong, YL:ylkwong@hku.hken_US
dc.identifier.authorityKwong, YL=rp00358en_US
dc.description.naturelink_to_OA_fulltexten_US
dc.identifier.doi10.1182/blood-2005-10-4175en_US
dc.identifier.pmid16554490-
dc.identifier.scopuseid_2-s2.0-33645521562en_US
dc.identifier.hkuros118863-
dc.relation.referenceshttp://www.scopus.com/mlt/select.url?eid=2-s2.0-33645521562&selection=ref&src=s&origin=recordpageen_US
dc.identifier.volume107en_US
dc.identifier.issue7en_US
dc.identifier.spage3012en_US
dc.identifier.epage3013en_US
dc.identifier.isiWOS:000236656900072-
dc.publisher.placeUnited Statesen_US
dc.identifier.scopusauthoridAu, WY=7202383089en_US
dc.identifier.scopusauthoridTam, S=7202037323en_US
dc.identifier.scopusauthoridFong, BM=16507017100en_US
dc.identifier.scopusauthoridKwong, YL=7102818954en_US
dc.identifier.issnl0006-4971-

Export via OAI-PMH Interface in XML Formats


OR


Export to Other Non-XML Formats